2016 AAPB Webinar 11: Identifying Diffuse Axonal Interruptions or Injuries Through QEEG and Promote
Presented by: Dave Siever, CET, Mind Alive Inc.
No CEU's available for this recording.
Available for download after purchase
This webinar begins with an explanation of a diffuse axonal interruption or injury (DAI) and the brain regions affected. It explains EEG tracings and how they relate to DAIs. It explains certain aspects of qEEGs, primarily magnitude and phase measurements. Alongside this learning is an introduction to audio-visual entrainment (AVE) and its principles of operation. The final part of this webinar contains well documented cases of people struggling with DAIs, how their lives have been affected and how AVE used in a counter-intuitive way has given them a second chance at regaining their lives, occupations, social life and good mental health.
Professionals who complete this webinar will gain:
- Understand the mechanisms of a diffuse axonal interruption or injury (DAI).
- Learn the signature of a DAI on a qEEG.
- Learn the physiological basis of Audio-Visual Entrainment.
- See clinical outcomes of some cases involving DAI.
Prerequisites: None. Advance preparation is not required.
Dave Siever graduated in 1978 as an engineering technologist. He later worked in the Faculty of Dentistry at the University of Alberta designing TMJ Dysfunction related diagnostic equipment and research facilities. He organized research projects, taught basic physiology and the advanced TMJ diagnostics course. Dave had noted anxiety issues in many patients suffering with TMJ dysfunction, prompting him to study biofeedback, which he applied to the patients and then later, Dave designed biofeedback devices. In 1984, Dave designed his first audio-visual entrainment (AVE) device - the "Digital Audio-visual Integration Device," or DAVID1. Since this time, through his company, Mind Alive Inc., Dave has been researching and refining AVE technology since, specifically for use in relaxation, boosting academic performance and treating anxiety, depression, PMS, ADD, FMS, SAD, pain, cognitive decline and insomnia, which he presents primarily at various conferences and for special interest medical/psychology groups. Dave also designs Cranio-Electro Stimulation (CES) products and is a leading provider of transcranial DC stimulation (tDCS) and devices. As a result of Dave's commitment to research, Mind Alive Inc now owns three patents involving neurotechnology. Dave continues to conduct research, perform a quantitative EEG service and designs new products pertaining to enhanced performance and mental wellness.